Education & Training
- Columbia University (BS)
- SUNY / Buffalo (MA)
- SUNY HSC at Syracuse (MD)
- SUNY HSC at Syracuse (Internship / Residency)
- M.D. Anderson Cancer Center (Fellowship)
Schmitt NC, Sharma, Gilbert MR, Kim S. Early T stage salivary duct carcinoma: outcomes and implications for patient counseling. Otolaryngol head Neck Surg. 2015 Nov;153(5):795-8. doi: 10.177/0194599815601659. Epub 2015 Aug 25.
Kim J, Kim S, Albergotti WG, Choi PA, Kaplan DJ, Abberbock S, Johnson JT, Gildener-Leapman N. Selection of ideal candidates for surgical salvage of head and neck squamous cell carcinoma: effect of the charlson-age comorbidity index and oncologic characteristics on 1-year survival and hospital course. JAMA Otolaryngol Head Neck Surg. 2015 Oct 8:1-8. Doi: 10.1001/jamaoto.2015.2158. (Epub ahead of print)
Davis KM, Lim CM, Clump DA, Heron DE, Ohr JP, Kim S, Duvvuri U, Johnson JT, Ferris RL. Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer. Head Neck. 2015 Dec 17. doi: 10.1002/hed.24287 [Epub ahead of print]
Maxwell JH, Thompson LD, Brandwein-Gensler MS, Weiss BG, Canis M, Purgina B, Prabhu AV, Lai C, Shuai Y, Carroll WR, Morlandt A, Duvvuri U, Kim S, Johnson JT, Ferris RL, Seethala R, Chiosea Sl. Early oral tongue squamous cell carcinoma: sampling of margins from tumor bed and worse local control. JAMA Otolaryngol Head Neck Surg. 2015 Dec 1; 141(12):1104-10. doi: 10.1001/jamaoto.2015.1351
Kim S and Shillitoe E. Human papillomaviruses in HNSCC. In Head and Neck Cancer (Ensley J, Gutkind S,Jacobs JR, and Lippman, SM, Eds) Academic Press, San Diego.
Kim S and Weber RS. Hypopharyngeal Cancer. In Otolaryngology – Head and Neck Surgery, 4th Edition (Bailey BJ, Johnson JT, Newlands S, Eds) Lippincott, Williams and Wilkins, Philadelphia, 2006, Vol. 2, Chapter 119, pp. 1691-1710.
Gilbert MR, Lim CM, Kim S. Head and Neck Cancer. In Metastasis: Modeling and Analysis. Springer. Chapter 2, pp. 7-26
Christopoulos, A., Ahn, S. M., Klein, J. D., Kim, S. , Biology of vascular endothelial growth factor and its receptors in head and neck cancer: Beyond angiogenesis. Head & Neck, n/a. doi: 10.1002/hed.21588
Hsu HW, Wall NR, Hsueh CT, Kim S, Ferris RL, Chen CS, Mirshahidi S. Combination antiangiogenic therapy and radiation in head and neck cancers. Oral Oncol. 2014 Jan;50(1):19-26. Epub 2013 Oct 23
Research Interest Summary
Dr. Kim’s clinical interests include advanced skin cancer, oral cancer, and thyroid cancer. He has authored several publications regarding the development of novel therapies for thyroid cancer and is currently working to develop antiangiogenic and targeted therapy for head and neck cancer.
NIH R21 Exploratory / Development Grant R21DE024527, Mechanism of Perineural Invasion in Head and Neck Cancer, 7/2014-6/2015, National Institute of Health
NIH K08 Mentored Clinical Scientist Development Award K08DE019201, Concurrent Inhibition of EGFR and VEGFR in Oral Squamous Cell Carcinoma, 9/2008-6/2013, National Institute of Health